Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Broncus HoldingBRNHF 43 Quick Ratio is 22.04 as of Dec. 2025, which is at its 10-year median of 22.04. GuruFocus rates BRNHF with a GF Score™ of 43/100. The stock has 7 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Broncus Holding ranks better than 98.83% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Broncus Holding's quick ratio for the quarter that ended in Dec. 2025 was 22.04.
Broncus Holding has a quick ratio of 22.04. It generally indicates good short-term financial strength.
The historical rank and industry rank for Broncus Holding's Quick Ratio or its related term are showing as below:
BRNHF'
s Quick Ratio Range Over the Past 10 Years
Min: 0.51 Med: 22.04 Max: 26.77
Current: 22.04
During the past 7 years, Broncus Holding's highest Quick Ratio was 26.77. The lowest was 0.51. And the median was 22.04.
BRNHF's Quick Ratio is ranked better than 98.83% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs BRNHF: 22.04
Broncus Holding (OTCPK:BRNHF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Broncus Holding Quick Ratio Related Terms
Broncus Holding Quick Ratio Historical Data
* Premium members only.
The historical data trend for Broncus Holding's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Broncus Holding's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Broncus Holding Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Broncus Holding's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Broncus Holding's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Broncus Holding's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Broncus Holding (BRNHF) has a Quick Ratio of 22.04 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Broncus Holding and its competitors. This is near median its historical median of 22.04. Over the past decade, Broncus Holding's Quick Ratio has ranged from 0.51 to 26.77. According to the industry distribution chart, Broncus Holding ranks #10 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 1.2%.
Is Broncus Holding's Quick Ratio too high?
Broncus Holding's current Quick Ratio of 22.04 is near median its 10-year median of 22.04. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 26.77. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Broncus Holding's value of 22.04 is 1066.1% above this industry median. Based on the distribution chart, Broncus Holding ranks #10 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Broncus Holding has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Broncus Holding's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Broncus Holding ranks #10 out of 852 companies for Quick Ratio. This places Broncus Holding in the top 1% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.89. Broncus Holding's value of 22.04 is 1066.1% above this benchmark. Historically, Broncus Holding's own Quick Ratio has ranged from 0.51 to 26.77 over the past decade. While the company's 10-year median is 22.04 vs. the industry median of 1.89, Broncus Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Broncus Holding's current Quick Ratio of 22.04 is 1066.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Broncus Holding and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Broncus Holding's current Quick Ratio is 22.04, which is near median its own 10-year median of 22.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Broncus Holding stock overvalued right now?
Broncus Holding (BRNHF) has a current Quick Ratio of 22.04. The current Quick Ratio is 22.04, which is near median its 10-year median of 22.04 and 1066.1% above the Medical Devices & Instruments industry median of 1.89. Broncus Holding's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Broncus Holding (BRNHF), the current Quick Ratio is 22.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
43GF Score
Get the complete analysis for BRNHF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRNHF has been successfully added to your 
